Author: Ookla - Providing network intelligence to enable modern connectivity

The FDA’s refusal to review Moderna’s mRNA-based flu vaccine is “part of a disturbing pattern” of moving regulatory goalposts, according to Clay Alspach, executive director of the Alliance for mRNA Medicines. Meanwhile, streamlined communications with regulators in other countries pave the way for rapid uptake of novel modalities.Read More

Read More

As American and European policymakers know well, global currency dominance and exchange rate movement are different things. But there’s a decent argument that Europe’s push to widen euro usage necessarily involves some revaluation of the single currency.Read More

Read More